Emageon Receives 'Best in KLAS' Cardiology ...(ization and infrastructure tools for the...),Health
Navigation Links
Emageon Receives 'Best in KLAS' Cardiology PACS Award
Date:3/26/2008
ization and infrastructure tools for the clinical analysis and management of digital medical images, reports and associated clinical content. Emageon's standards-based solutions are designed to help customers enhance patient care, automate workflow, lower costs, improve productivity and provide better service to physicians. For more information, please visit http://www.emageon.com.
About KLAS
KLAS is a research firm that specializes in monitoring and reporting the performance of healthcare's information technology (HIT) vendors. KLAS' mission is to improve HIT delivery by independently measuring vendor performance for the benefit of its healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the HIT industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to http://www.KLASresearch.com
*(C) 2008 KLAS Enterprises, LLC. All rights reserved.
'/>"/>
| SOURCE Emageon Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Emageon to Present at Raymond James 29th Annual Institutional Investors Conference
2. Emageon Reports Fourth Quarter and 2007 Financial Results
3. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
4. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
5. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
6. Emageon Names Chris E. Perkins as Chief Operating Officer
7. Emageon Reports Third Quarter 2007 Financial Results
8. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
9. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
10. Alsius Corporation Receives Regulatory Approval in China and Mexico
11. North American Insurance Leaders, Inc. Receives an Estimate of Deep South 2007 Governing EBITDA
Post Your Comments:
(Date:5/20/2008)...Vista Partners announced today that,it has initiat...aq: ALSE ).,Ross Silver, Director of Research of ...in-based drug named Cethrin has shown highly encou...rin would serve a multi-billion,dollar market if a...ecular,imaging program in Phase III clinical trial...
(Date:5/20/2008)...- ASINEX and Collaborative Drug,Discovery (CDD), I...high,value compound libraries via the CDD Communit...e ASINEX Lead Generation Library with additional,l...ecial screening sets,tailored to the specific need...y) academic researchers. The combined information ...
(Date:5/20/2008)...f Medical Records Into a User,s New ..., May 20 /PRNewswire/ -- UNIVAL, Inc., a healthcar...althcare services,announced today that it is inte...h is a new product that launched yesterday which a...edical records online. The UNIVAL,integrated servi...
(Date:5/20/2008)...Dr. Philip Goglia, known as the,"nutritionist to t...es,including Owen Wilson, Mandy Moore, Raven Symon...lum, will help to launch SlimShots(TM), a liquid,a...and is now available in,the United States., Over ...ness Concepts is,the premier nutrition and fitness...
Breaking Medicine News(10 mins):Health News:Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) 2Health News:ASINEX and CDD Team up for Open Access Data for the Scientific Community 2Health News:ASINEX and CDD Team up for Open Access Data for the Scientific Community 3Health News:UNIVAL, Inc. Becomes a Google Health(TM) Integrated Service 2Health News:'Nutritionist to the Stars' Helps to Launch European Liquid Appetite Controller 2[0] Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)[0] ASINEX and CDD Team up for Open Access Data for the Scientific Community[0] UNIVAL, Inc. Becomes a Google Health(TM) Integrated Service[0] 'Nutritionist to the Stars' Helps to Launch European Liquid Appetite Controller
...ntists have identified a protein in the brain of r...y haven't yet tested how the protein behaves in hu...es at the Institute of Neuroscience of the Consigl... Research Council) in Rome spotted the TLQP-21 pro...
...AGO - Patients with allergic rhinitis, such as tha...re difficulty sleeping and more sleep disorders// ...t in the September 18 issue of Archives of Interna...llergic rhinitis, which occurs when pollen or othe...
... the expansion of the NHS ?12 billion computer sys... 110 "major incidents" in four months//. These pro...X-rays on screens in operating theatres. Details o...ve also been left inaccessible on several occasion...
...cent report by the Ministry in Jamaica has reveale...n Jamaica, in a paper that has now come before the...ple infected with the HIV virus live healthy lives...loping the full-blown disease, many others don't. ...
Other Medicine News:Health News:Allergic Rhinitis Associated with Impaired Sleep Quality 2Health News:NHS Inconvenienced by 110 major computer failures 2(Date:5/20/2008)...e-FirstCall/ -- An interim analysis of a,study pre...Week (DDW),Conference found that, among patients a...ed an annual fecal immunochemical (FIT) test, dete...26.5 months earlier than would,have occurred durin...py.,Detection of precancerous lesions in this grou...
(Date:5/20/2008)...FirstCall/ -- Omeros Corporation today,announced t...1 study of,OMS201, the Company,s second PharmacoSu...rological surgery. At least 24 patients undergoing... maximum diameter of 12 mm,located in the renal-co...study., "Advancing another PharmacoSurgery(TM) pr...
(Date:5/20/2008)...romist(TM) (Formoterol Fumarate) Inhalation ...ce --, NAPA, Calif., May 20 /- Data ... the American Thoracic Society (ATS) demonstrate,t...ation Solution,(formoterol fumarate inhalation sol...va(R) (tiotropium; TIO) is significantly more effe...
(Date:5/20/2008)...nternational Conference of the American ...0 /- Forest Laboratories, I...d results from four clinical,trials assessing the ...stigational treatment for chronic obstructive pulm...tudies further describing the properties of,aclidi...
Breaking Medicine Technology:Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 2Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 3Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 4Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds 5Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 1Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 2Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 3Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile 321 4Pregnancy may slow not accelerate progression to AIDS 1581 1Pregnancy may slow not accelerate progression to AIDS 1581 2Pregnancy may slow not accelerate progression to AIDS 1581 3Why are some groups of animals so diverse 3F 1579 1Why are some groups of animals so diverse 3F 1579 2Canadas pristine freshwater fisheries at risk 457 1Canadas pristine freshwater fisheries at risk 457 2Canadas pristine freshwater fisheries at risk 457 3[0] Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds[0] Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study[0] Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone[0] Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
...007 /PRNewswire/ -- Alfacell,Corporation today ann...sident, chief financial officer and corporate secr...roduct development programs,at 8 a.m. EDT on Thurs...Emerging Growth Opportunities Conference in New Yo...ilable live at,<a target="_blank" href=,"http://ww...
...UNSWICK, New Jersey, July 03, 2007,/PRNewswire-Fir...NA,company, announced today that J. Michael French...nterberg, Towbin Emerging Growth,Opportunities Con...e Mandarin Oriental Hotel in New York. , A live au...on,the "Investors" section of the company,s websit...
Other Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2...ists steerable guidewires across difficult lesions...eter offers a low profile (3F-4F) and is compatibl... crossing difficult occlusions. Once the occlusio...guidewire position and an angioplasty balloon is d...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick
...copic navigation system that tracks multiple intra...d Wittkampf, Ph.D., and is being developed by Surg...,The LocaLisa system uses three skin electrode p...art to track catheters. Using a reference electrod...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |